Dong-Mei Feng
Beijing United Family Hospital(CN)The Family Center(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Prostate Cancer Treatment and Research, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Neuropeptides and Animal Physiology, Blood Coagulation and Thrombosis Mechanisms
Most-Cited Works
- → A peptide–doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo(2000)157 cited
- → Species Variability in Platelet and other Cellular Responsiveness to Thrombin Receptor-derived Peptides(1994)99 cited
- → An Antibody Against the Exosite of the Cloned Thrombin Receptor Inhibits Experimental Arterial Thrombosis in the African Green Monkey(1995)94 cited
- → The Synthesis of a Prodrug of Doxorubicin Designed to Provide Reduced Systemic Toxicity and Greater Target Efficacy(2001)81 cited
- → Design, synthesis and bioassays of antagonists of LHRH which have high antiovulatory activity and release negligible histamine(1987)69 cited
- → Development of a Potent Thrombin Receptor Ligand(1995)60 cited
- → Discovery of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors Incorporating Aminopyridyl Moieties at the P1 Position(1997)57 cited
- → Design and Synthesis of a Pro-Drug of Vinblastine Targeted at Treatment of Prostate Cancer with Enhanced Efficacy and Reduced Systemic Toxicity(2002)53 cited
- PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolites.(2001)
- A prostate-specific antigen (PSA)-activated vinblastine prodrug selectively kills PSA-secreting cells in vivo.(2002)